{"DataElement":{"publicId":"7342870","version":"1","preferredName":"Ancillary Study If Yes Specify Prothrombin Time Float","preferredDefinition":"A measurement from secondary study data capturing the clotting time of plasma recalcified in the presence of excess tissue thromboplastin in seconds.","longName":"7342494v1.0:6848361v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7342494","version":"1","preferredName":"Ancillary Study If Yes Specify Prothrombin Time","preferredDefinition":"A study that is secondary to another study._A directive to provide a more specific response if the answer to the question is yes._A measurement of the clotting time of plasma recalcified in the presence of excess tissue thromboplastin; it is a measure of the extrinsic pathway of coagulation. It is used to determine the clotting tendency of blood, in the measure of warfarin dosage, liver damage and vitamin K status. Factors measured are fibrinogen, prothrombin, and factors V, VII, and X.","longName":"7052721v1.0:7342600v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"7052721","version":"1","preferredName":"Ancillary Study","preferredDefinition":"A study that is secondary to another study.","longName":"C16041","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ancillary Study","conceptCode":"C16041","definition":"A study that is secondary to another study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"973C983C-51FC-1152-E053-F662850AE6FF","latestVersionIndicator":"Yes","beginDate":"2019-11-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-13","modifiedBy":"ONEDATA","dateModified":"2019-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7342600","version":"1","preferredName":"Specify if Yes Prothrombin Time","preferredDefinition":"A directive to provide a more specific response if the answer to the question is yes.:A measurement of the clotting time of plasma recalcified in the presence of excess tissue thromboplastin; it is a measure of the extrinsic pathway of coagulation. It is used to determine the clotting tendency of blood, in the measure of warfarin dosage, liver damage and vitamin K status. Factors measured are fibrinogen, prothrombin, and factors V, VII, and X.","longName":"C157104:C62656","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify if Yes","conceptCode":"C157104","definition":"A directive to provide a more specific response if the answer to the question is yes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Prothrombin Time","conceptCode":"C62656","definition":"A measurement of the clotting time of plasma recalcified in the presence of excess tissue thromboplastin; it is a measure of the extrinsic pathway of coagulation. It is used to determine the clotting tendency of blood, in the measure of warfarin dosage, liver damage and vitamin K status. Factors measured are fibrinogen, prothrombin, and factors V, VII, and X.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8DB4057-EAAB-67EF-E053-4EBD850A597F","latestVersionIndicator":"Yes","beginDate":"2020-06-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-24","modifiedBy":"ONEDATA","dateModified":"2020-06-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8D99EEA-CDB8-5821-E053-4EBD850A86E3","latestVersionIndicator":"Yes","beginDate":"2020-06-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-24","modifiedBy":"KNABLEJ","dateModified":"2020-07-09","changeDescription":"7/9/20 jk Released per SME (NGM) review and approval 7/6 email.  6/24/20 jk created for CPTAC LIHC baseline CRFs based on edited CRF/emails from SME.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6848361","version":"1","preferredName":"Float","preferredDefinition":"A number that can have its decimal point in any position.","longName":"6848361v1.0","context":"OCCPR","contextVersion":"1","type":"Non-enumerated","dataType":"java.lang.Float","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433735","version":"1","preferredName":"Float","preferredDefinition":"A number that can have its decimal point in any position.","longName":"C48150","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Float","conceptCode":"C48150","definition":"A number that can have its decimal point in any position.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4760-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-25","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-25","modifiedBy":"ONEDATA","dateModified":"2005-11-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8F897786-62CB-4E64-E053-F662850A2D6F","latestVersionIndicator":"Yes","beginDate":"2019-08-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-08-07","modifiedBy":"KNABLEJ","dateModified":"2020-06-27","changeDescription":"6/27/20 jk Released per SME (NGM) review and approval.  2/13/20 jk added RS.  8/7/19 jk generic VD created for use in multiple CPTAC CRF questions.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"6776762","version":"1","longName":"Bile duct and Liver","context":"OCCPR"},{"publicId":"6779538","version":"1","longName":"CHOL Baseline","context":"OCCPR"},{"publicId":"6779541","version":"1","longName":"LIHC Baseline","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"If Yes, specify: Time (Second","type":"Preferred Question Text","description":"If Yes, specify: Time (Seconds):","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A8DB700A-7E13-6B8F-E053-4EBD850AF7B7","latestVersionIndicator":"Yes","beginDate":"2020-06-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-24","modifiedBy":"KNABLEJ","dateModified":"2020-07-09","changeDescription":"7/9/20 jk Released per SME (NGM) review and approval 7/6 email.  6/24/20 jk Created for CPTAC LIHC baseline v1.03 CRF revision.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}